Company Name: |
Shanghai Chaolan Chemical Technology Center
|
Tel: |
QQ:65489617 15618227136 |
Email: |
info@SuperLan-chem.com |
Products Intro: |
Product Name:K-756 CAS:130017-40-2 Purity:98% Package:5MG;10MG;50MG;100MG,1G,5G,100G
|
Company Name: |
Angel Pharmatech, Ltd.
|
Tel: |
17317130613 |
Email: |
3358272972@qq.com |
Products Intro: |
Product Name:K-756 CAS:130017-40-2 Purity:98% HPLC Package:1G;5G
|
|
Product Name: | K-756 | Synonyms: | K-756;2(1H)-Quinazolinone, 3-[[1-(6,7-dimethoxy-4-quinazolinyl)-4-piperidinyl]methyl]-3,4-dihydro-;K-756 >=98% (HPLC);K-756,PARP,Inhibitor,poly ADP ribose polymerase,K756,K 756,inhibit | CAS: | 130017-40-2 | MF: | C24H27N5O3 | MW: | 433.5 | EINECS: | | Product Categories: | | Mol File: | 130017-40-2.mol | ![K-756 Structure](CAS/20200515/GIF/130017-40-2.gif) |
| K-756 Chemical Properties |
Melting point | 216-218 °C | Boiling point | 680.0±55.0 °C(Predicted) | density | 1.261±0.06 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO:4.55(Max Conc. mg/mL);10.5(Max Conc. mM) | pka | 14.92±0.20(Predicted) | form | Solid | color | White to off-white |
| K-756 Usage And Synthesis |
Description | K-756 is a a selective Wnt/β-catenin pathway inhibitor. K-756 is also a tankyrase (TNKS) inhibitor. K-756 binds to the induced pocket of TNKS and inhibits its enzyme activity. could be a leading compound in the development of anticancer agents. | in vitro | K-756 binds to the induced pocket of TNKS and inhibits its enzyme activity. Moreover, PARP family enzyme assays showed that K-756 is a selective TNKS inhibitor. K-756 inhibited the cell growth of APC-mutant colorectal cancer COLO 320DM and SW403 cells by inhibiting the Wnt/β-catenin pathway. _x000D_
_x000D_
Reference: Mol Cancer Ther. 2016 Jul;15(7):1525-34. https://pubmed.ncbi.nlm.nih.gov/27196752/ | in vivo | An in vivo study showed that the oral administration of K-756 inhibited the Wnt/β-catenin pathway in colon cancer xenografts in mice._x000D_
_x000D_
Reference: Mol Cancer Ther. 2016 Jul;15(7):1525-34. https://pubmed.ncbi.nlm.nih.gov/27196752/ | target | K-756 is a direct and selective tankyrase (TNKS) inhibitor, which inhibits the ADP-ribosylation activity of TMS1 amd TMLS2 with IC50s of 31 and 36 nM, respectively. |
| K-756 Preparation Products And Raw materials |
|